Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV
Clinical trial NCT01601626 · TERMINATED
Trial details
- NCT number
- NCT01601626
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-13
- Primary completion
- 2017-01-19
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.